Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (11-20 of 384) with videos related to

Pageof 39
Sort By:
Seminars in Thrombosis and Hemostasis|November 5, 1999
In vitro studies on the biochemistry and pharmacology of low molecular weight heparinsW Jeske, J Fareed
Seminars in Thrombosis and Hemostasis|November 5, 1999
Human pharmacokinetics of low molecular weight heparinsU Cornelli, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1996
Thromboembolic diseases: biochemical mechanisms and new possibilities of biological diagnosisJ Amiral, J Fareed
Thrombosis and Haemostasis|July 1, 1995
Comparative pharmacology of site directed antithrombin agents. Implication in drug developmentD Callas, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1993
Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analoguesW Jeske, J Fareed
Seminars in Thrombosis and Hemostasis|September 30, 2000
Heparins in the new millennium: will unfractionated heparin survive? EpilogueJ Fareed, D A Hoppensteadt
International Angiology : a Journal of the International Union of Angiology|December 20, 2007
Management of deep vein thrombosisA N Nicolaides, J Fareed
Seminars in Thrombosis and Hemostasis|October 1, 1983
Current trends in hemostatic testingJ Fareed, J M Walenga
Thrombosis Research|September 15, 1996
Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time methodD D Callas, J Fareed
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Low molecular weight heparins: differences and similarities in approved preparations in the United StatesR L Bick, J Fareed
Pageof 39

Showing results (11-20 of 384) with videos related to

Sort By:
Pageof 39
Seminars in Thrombosis and Hemostasis|November 5, 1999
In vitro studies on the biochemistry and pharmacology of low molecular weight heparinsW Jeske, J Fareed
Seminars in Thrombosis and Hemostasis|November 5, 1999
Human pharmacokinetics of low molecular weight heparinsU Cornelli, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1996
Thromboembolic diseases: biochemical mechanisms and new possibilities of biological diagnosisJ Amiral, J Fareed
Thrombosis and Haemostasis|July 1, 1995
Comparative pharmacology of site directed antithrombin agents. Implication in drug developmentD Callas, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1993
Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analoguesW Jeske, J Fareed
Seminars in Thrombosis and Hemostasis|September 30, 2000
Heparins in the new millennium: will unfractionated heparin survive? EpilogueJ Fareed, D A Hoppensteadt
International Angiology : a Journal of the International Union of Angiology|December 20, 2007
Management of deep vein thrombosisA N Nicolaides, J Fareed
Seminars in Thrombosis and Hemostasis|October 1, 1983
Current trends in hemostatic testingJ Fareed, J M Walenga
Thrombosis Research|September 15, 1996
Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time methodD D Callas, J Fareed
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Low molecular weight heparins: differences and similarities in approved preparations in the United StatesR L Bick, J Fareed
Pageof 39